Detalles de la búsqueda
1.
Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover study.
Eur J Neurol
; 27(11): 2209-2216, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32558044
2.
Informing MS patients on treatment options: a consensus on the process of consent taking.
Neurol Sci
; 41(8): 2249-2253, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32240416
3.
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
J Neurol Neurosurg Psychiatry
; 87(9): 944-51, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27160523
4.
Natalizumab discontinuation and disease restart in pregnancy: a case series.
Acta Neurol Scand
; 131(5): 336-40, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25598313
5.
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.
Mult Scler
; 20(1): 72-80, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23812283
6.
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
Int J Immunopathol Pharmacol
; 27(2): 147-54, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25004826
7.
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.
Mult Scler
; 18(6): 835-42, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22127896
8.
Initial oak regeneration responses to experimental warming along microclimatic and macroclimatic gradients.
Plant Biol (Stuttg)
; 24(5): 745-757, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35373433
9.
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
Mult Scler
; 17(8): 991-1001, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21502310
10.
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.
Mult Scler
; 17(12): 1432-40, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21729978
11.
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.
Eur J Neurol
; 18(9): 1122-31, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21362108
12.
Tailored Vessel-Catheter Diameter Ratio in a Direct Aspiration First-Pass Technique: Is It a Matter of Caliber?
AJNR Am J Neuroradiol
; 42(3): 546-550, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33478941
13.
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia.
J Neurol Sci
; 424: 117430, 2021 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33838554
14.
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
Funct Neurol
; 24(3): 159-62, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-20018144
15.
Alexithymia in multiple sclerosis: relationship with fatigue and depression.
Acta Neurol Scand
; 118(1): 18-23, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18162056
16.
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients.
Cell Death Dis
; 6: e1741, 2015 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25950471
17.
Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1a.
J Interferon Cytokine Res
; 18(5): 345-50, 1998 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-9620362
18.
A one-year study on the pharmacodynamic profile of interferon-beta1a in MS.
Neurology
; 58(9): 1409-11, 2002 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-12011292
19.
Effect of steroids on Gd-enhancing lesions before and during recombinant beta interferon 1a treatment in relapsing remitting multiple sclerosis.
Neurology
; 50(2): 403-6, 1998 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-9484362
20.
Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis.
Neurology
; 50(1): 238-44, 1998 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-9443486